Product Images Potassium Citrate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Potassium Citrate NDC 31722-132 by Camber Pharmaceuticals, Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
10 mEq-100s - 10 mEq 100s
15 mEq-100s - 15 mEq 100s
Potassium Citrate Extended-Release Tablets, USP are a prescription medication in a 100 tablet package. The tablets are oval-shaped and off-white to tan-yellowish in color. Each 15 mEq tablet is debossed with ‘T’ on one side and ‘401” on the other side. It is recommended to read the package insert for dosage information. These tablets are manufactured by Ascent Pharmaceuticals, Inc. in Central Islip, NY 11722, for Camber Pharmaceuticals, Inc. in Piscataway, NJ 08854. They must be stored at 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F).*
5 mEq-100s - 5 mEq 100s
This is a description of a prescription drug with the NDC code 31722-129-01. The drug is called Potassium Citrate Extended-Release Tablets, USP and each tablet contains 5 mEq (540 mg) of potassium citrate. This medication is used to treat certain types of kidney stones. The tablets are uncoated, round and either white or tan/yellowish in color. The label recommends storing the drug in a light container with consistent sealing, between temperatures of 20°C to 25°C. This medication is dispensed in batches of 100 tablets, with dosage information contained in the package insert. The manufacturer is Ascent Pramaceuticals, located in Central Islip, NY, and the pharmaceutical company Camber Pharmaceuticals located in Piscataway, NJ.*
structure - Structure
Table 1.
The text presents a table showing the effect of Potassium Citrate in patients with Calcium Oxalate Nephrolithiasis. The table shows the number of stones formed per year for each group before and during treatment with Potassium Citrate. The table also includes the percentage of patients in each group who experienced remission (remaining free of newly formed stones during treatment) and any decrease in stones formed.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.